PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Biomedicines0 citationsOpen Access

Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells’ Transcriptional Profile: Role of Shuttled miRNAs

View Full Paper
LGLuca GiacchiAUArgia UcciVZVeronica Zelli

Key Points

  • The aim is to explore how osteoblast-derived extracellular vesicles affect osteosarcoma cells and their transcriptional profiles.
  • Used phenotypic assays to assess cell behaviours in human osteosarcoma cell lines after OB-EV treatment.
  • Conducted RNA sequencing on treated cells to analyze transcriptomic changes.
  • Performed miRNA profiling to identify highly expressed miRNA in OB-EVs.
  • OB-EVs reduced metabolic activity by 1.30-fold and proliferation by 1.70-fold in U2OS cells, while increasing apoptosis by 1.15-fold.
  • In MG63 cells, OB-EVs increased proliferation by 4.9-fold without affecting aggressiveness.
  • Found 296 differentially expressed genes in MNNG/HOS cells, indicating significant transcriptomic alterations.

Abstract

Background/Objectives: Osteosarcoma is the most common primary malignant bone tumour, affecting children and young adults. Recent evidence suggests that extracellular vesicles (EVs), small membrane-bound nanoparticles released by all cell types, play a key role in intercellular communication within the tumour microenvironment. Therefore, we aimed to investigate the effects of osteoblast-derived EVs (OB-EVs) on osteosarcoma cell behaviour and to characterise the transcriptional and miRNA-mediated mechanisms underlying these effects. Methods: Phenotypic assays were performed to assess metabolic activity, proliferation, apoptosis, and invasion ability of human osteosarcoma cell lines after treatment with OB-EVs. Illumina-based RNAseq was conducted on RNA isolated from OB-EVs-treated cells, and qRT-PCR was assessed using commercially available TaqMan miRNA cards on RNA isolated from OB-EVs. Results: In U2OS cells, OB-EVs reduced metabolic activity (1.30-fold decrease, p = 0.0137) and proliferation (1.70-fold decrease, p = 0.017) while increasing apoptosis (1.15-fold increase, p = 0.014). In MG63, OB-EVs increased proliferation (4.9-fold increase, p = 0.020) without affecting tumour cell aggressiveness, while normal osteoblast behaviour was not affected by OB-EVs. MNNG/HOS cells treated with OB-EVs for 48 h showed substantial transcriptomic changes, with 296 differentially expressed genes (97 up- and 199 down-regulated in OB-EVs treated cells versus untreated cells), indicating a direct impact of OB-EVs on gene expression. Intriguingly, Gene Set Enrichment Analysis (GSEA) showed trends consistent with modulation of signalling pathways, including Wnt/β-catenin and NOTCH. Conversely, miRNA profiling of OB-EVs identified 13 highly expressed miRNA. Integration of transcriptomic and miRNA target prediction data highlighted convergent pathway-level signals, suggesting that OB-EVs may modulate tumour-associated regulatory networks. Conclusions: Taken together, these findings indicate that OB-EVs modulate osteosarcoma cell phenotype, with miRNA shuttling representing a potentially relevant contributing mechanism. The integrative analysis suggests that pathways associated with proliferation and cellular homeostasis, including Wnt/β-catenin signalling, may be involved, although further functional validation is required to confirm these mechanisms.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Giacchi et al. (2026) studied this question.

synapsesocial.com/papers/69fa980604f884e66b531dd0https://doi.org/10.3390/biomedicines14051039
Ask AI
Helpful
Bookmark
Share
View Full Paper